Insiders / Fitzgerald Kevin Joseph / Activity
Activity — Fitzgerald Kevin Joseph
61 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $677.5K | -2K -8.76% | 21,264 0.02% of shares | medium |
| Feb 13, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $607.4K | -2K -7.75% | 23,305 0.02% of shares | medium |
| Jan 13, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $238.3K | -644 -2.83% | 22,151 0.02% of shares | medium |
| Mar 3, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $231.4K | -722 -3.15% | 22,219 0.02% of shares | medium |
| Jan 13, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $207.2K | -562 -2.41% | 22,795 0.02% of shares | medium |
| Jan 13, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $180.1K | -485 -2.19% | 21,666 0.02% of shares | medium |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $128.1K | -392 -1.59% | 24,323 0.02% of shares | medium |
| Mar 3, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $115.4K | -359 -1.62% | 21,860 0.02% of shares | medium |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $107.8K | -329 -1.35% | 23,994 0.02% of shares | medium |
| Jan 13, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $104.4K | -280 -1.29% | 21,386 0.02% of shares | medium |
| Mar 3, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $91.5K | -289 -1.23% | 23,223 0.02% of shares | low |
| Mar 3, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $89.9K | -282 -1.21% | 22,941 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $84.0K | -258 -1.03% | 24,715 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $80.4K | -220 -0.91% | 23,846 0.02% of shares | low |
| Mar 5, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $75.3K | -233 -1.10% | 20,870 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $72.6K | -199 -0.82% | 24,066 0.02% of shares | low |
| Jan 13, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $72.4K | -197 -0.84% | 23,357 0.02% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $68.0K | -210 -0.97% | 21,359 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $56.1K | -170 -0.71% | 23,724 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $55.8K | -155 -0.63% | 24,483 0.02% of shares | low |
| Mar 5, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $49.9K | -153 -0.74% | 20,569 0.02% of shares | low |
| Mar 5, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $48.0K | -148 -0.71% | 20,722 0.02% of shares | low |
| Jan 13, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $45.7K | -122 -0.57% | 21,264 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $44.1K | -123 -0.50% | 24,723 0.02% of shares | low |
| Mar 5, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $39.9K | -124 -0.58% | 21,103 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $35.4K | -98 -0.40% | 24,385 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $34.3K | -96 -0.38% | 24,846 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $33.9K | -92 -0.39% | 23,663 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $32.9K | -100 -0.42% | 23,894 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $31.2K | -94 -0.40% | 23,549 0.02% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $31.0K | -96 -0.44% | 21,569 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $30.5K | -85 -0.34% | 24,638 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $29.2K | -90 -0.36% | 24,973 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $26.8K | -81 -0.34% | 23,643 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $26.5K | -73 -0.30% | 24,312 0.02% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $25.4K | -79 -0.36% | 21,665 0.02% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $24.4K | -75 -0.35% | 21,284 0.02% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $18.9K | -59 -0.27% | 21,744 0.02% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $18.6K | -57 -0.27% | 21,227 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $18.3K | -50 -0.21% | 23,796 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $17.1K | -47 -0.19% | 24,265 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $15.2K | -47 -0.19% | 25,063 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $15.1K | -41 -0.17% | 23,755 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $14.9K | -42 -0.17% | 24,983 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $14.8K | -40 -0.17% | 23,623 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $14.6K | -41 -0.16% | 24,942 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $13.8K | -39 -0.16% | 25,025 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $12.3K | -37 -0.16% | 23,512 0.02% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $9.3K | -29 -0.13% | 21,831 0.02% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $9.0K | -28 -0.13% | 21,803 0.02% of shares | low |